TAE Life Sciences
  • Company
    • About Us
    • News
    • Events
    • Resources
    • Careers
  • BNCT
    • History
    • How it Works
    • Benefits of BNCT
    • BNCT Forum
    • BNCT Virtual Clinic
  • Pipeline
  • Technology
  • Contact Us
  • TAE.com
  • NEW EBOOK
  • Company
    • About Us
    • News
    • Events
    • Resources
    • Careers
  • BNCT
    • History
    • How it Works
    • Benefits of BNCT
    • BNCT Forum
    • BNCT Virtual Clinic
  • Pipeline
  • Technology
  • Contact Us
  • TAE.com
  • NEW EBOOK

Developing-targeted-drugs-for-boron-neutron-capture-therapy-to-treat-refractory-cancers

Home > Developing targeted drugs for boron neutron capture therapy to treat refractory cancers > Developing-targeted-drugs-for-boron-neutron-capture-therapy-to-treat-refractory-cancers

Previous StoryDeveloping targeted drugs for boron neutron capture therapy to treat refractory cancers
Have questions about BNCT? Get answers on our new BNCT Forum

Sign up for our latest news and information

* indicates required




TAE Life Sciences, 35 Parker, Irvine, CA 92618

* The TAE Life Sciences device and drugs are in development and not available for sale or commercial use

Copyright ©2023 TAE Life Sciences. All Rights Reserved. Privacy Policy